Latest Breaking News On - Vascular assessment study - Page 1 : comparemela.com

Proteomics International Laboratories Ltd (ASX:PIQ) Canagliflozin Lowers PromarkerD DKD Risk Prediction Scores

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce results showing a significant reduction in the PromarkerD risk scores of patients with type 2 diabetes after taking the diabetes medicine canagliflozin.

United statesWestern australiaRichard lipscombeJanssen research developmentRj lipscombe proteomics internationalProteomics international laboratories ltdProteomics internationalJanssen researchUniversity of western australiaCanagliflozin lowers promarkerdInternational laboratories ltdClinical medicinePrecision medicineVascular assessment studyAustralasian diabetes conferenceEditorial board

KidneyIntelX Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort

06.06.2022 - Data shared in oral presentation at American Diabetes Association 82nd Scientific Sessions and published in Kidney360 highlights importance in early understanding of cardiovascular risk, a leading cause of death in patients with diabetes and chronic . Seite 1

United statesAmerican diabetes associationScientific sessionsVascular assessment study

KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort

KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesChloe beaudoinCenters for diseaseExchange commissionDrug administrationRenalytix clinical laboratoryAmerican diabetes associationScientific sessionsVascular assessment studyRenalytix clinicalDisease controlBreakthrough device designationPrivate securities litigation reform actLianne applegarth

KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart

Data shared in oral presentation at American Diabetes Association 82nd Scientific Sessions® and published in Kidney360 highlights importance in early.

United statesChloe beaudoinCenters for diseaseExchange commissionDrug administrationRenalytix clinical laboratoryAmerican diabetes associationScientific sessionsVascular assessment studyRenalytix clinicalDisease controlBreakthrough device designationPrivate securities litigation reform actLianne applegarthNasdaq rnlxRenalytix plc

Investegate |Renalytix PLC Announcements | Renalytix PLC: Positive Study Results Published for KidneyIntelX

Investegate announcements from Renalytix PLC, Positive Study Results Published for KidneyIntelX

United statesNicholas mooreMichaelj donovanPaul mcmanus lianne applegarthPeter denardoJames mcculloughGary clarence daniel adamsJennifer houlihanCenters for diseaseDrug administrationPopulation health for wake forest baptistInvestec bankStudy results publishedMonitoring patient responseNew drugAssessment study